Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000437454

Medchemexpress LLC (E)-2-(3,4-dihydroxybenzoyl)-3-(2-oxo-3H-1,3-benzoxazol-5-yl)prop-2-enenitrile | 638213-98-6 | 98.3% | 322.27 | 10 MM 1 ML
SDP

Supplier:  Medchemexpress LLC HY11272010MM/1ML

Encompass_Preferred

AGL-2263 is a novel and potent inhibitor of both the insulin receptor (IR) and the insulin-like growth factor (IGF) receptor. It appears as a light yellow to yellow solid powder and is intended for research use only, not for human or veterinary use.

  • Inhibits the insulin receptor (IR) and insulin-like growth factor (IGF) receptor.
  • Available as a light yellow to yellow solid powder.
  • Stable at ambient temperature for ordinary shipping.
  • Soluble in DMSO (~100 mg/mL) and various formulations.
  • Demonstrates biological activity in vitro by inhibiting IR.
  • Can still allow insulin to phosphorylate ERK1/2 and AKT in some cellular contexts.

Catalog No. 50-004-37454


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.